Wednesday, September 18, 2019

Bellicum is designing a Double-Barrel, Next Generation CAR-T Therapy to Take on Pancreatic Cancer

Cancer of the pancreas is a deadly disease. It is rarely diagnosed at early stages where treatment could be more helpful, and there are few effective treatments for patients with advanced disease. So far, academic and industry research has failed to find a solution...

RNA-Focused Drug Development Emerging as a Dominant Treatment Modality

The surging scientific excitement surrounding RNA therapeutics is a little like realizing you can pick fruit off a tree without cutting it down, or pick a flower without uprooting the plant. In other words, RNA therapeutics manipulate the translation of genetic instructions as opposed to...

Oncolytics Developing New Drug to Energize the Immune System to Fight Defiant Pancreatic Cancer

Pancreatic cancer is one of the most deadly and aggressive cancers afflicting patients and confounding medical researchers. The drug development industry is replete with earnest failed attempts, including testing new immunotherapies at finding an effective therapy for this unmet medical need. As a recent...

MEI’s Oncology Programs Aim New Drug Development at Specific Genetic Targets with Breakthrough Potential

MEI Pharma is developing a new kind of small molecule epigenetic modifier in partnership with The Helsinn Group to treat acute myeloid leukemia (AML), a blood cancer that strikes mostly adults in their late 60s and leaves some patients with limited options for survival. The...

WuXi AppTec Named One of MIT Technology Review’s 50 Smartest Companies

  Shanghai, June 29, 2019 – WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announces that it has been selected as one of MIT Technology Review’s 50 Smartest Companies (TR50) for 2019....

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Launches DNA Encoded Library (DEL) Service Package “DELight” to...

SHANGHAI; BOSTON, Sep. 3, 2019 - WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing...